FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110348767> ?p ?o ?g. }

• W2110348767 endingPage "77" @default.
• W2110348767 startingPage "1157" @default.
• W2110348767 abstract "Proteases and their inhibitors have long been investigated in numerous tumor systems, and at the tumor growing front, their balance has been universally found to be shifted towards higher proteolytic activities. However, out of many promising serine and metalloproteinase inhibitors, none are included in cancer treatment regimens at present. The current search for active antiproteolytic compounds is in contrast to the classical approach developed by John Beard, who suggested treating advanced cancer by fresh pancreatic extracts whose antitumor activity was based on their proteolytic potential. We followed John Beard's recommendations by using purified pancreatic proenzymes/enzymes, trypsinogen/trypsin (TG/TR), chymotrypsinogen/chymotrypsin (CG/CH) and amylase (AM). The mixture of these enzymatic activities produces potent antimetastatic and antitumor effects in cellular, animal and human systems. The treatment of cultured tumor cells with TR and CH at nanomolar [corrected] concentrations, comparable to those achieved in the blood of the patients, causes complete arrest of the directional movement of metastatic cells. Conversely, the same treatment of normal cells results in enhanced motility and an accelerated closure of the gap created in cell monolayers. Further, treatment of cells with serine proteases results in the formation of cellular 3-dimensional structures such as lamellae, cell streams and aggregates. In some cell types, the aggregates are compacted via cadherin-based cell-cell communication systems and form compact spheroids. In the highly metastatic cells with lower cadherin expression, the ability to form spheroids also diminishes. Tumor cells unable to form spheroids when treated with proteases are subject to elimination by apoptosis. In contrast, a large proportion of cells that form spheroids remain viable, although they are metabolically suppressed. Protease-treated tumor cells contain a disrupted actin cytoskeleton and exhibit a loss of front-to-back polarity. We hypothesize that the provision of zymogens, rather than the enzymes, was of crucial importance to the clinical effectiveness in the human trials conducted by Beard and his co-workers. The precursor nature of the active enzymes may offer protection against numerous serpins present in the tissues and blood. Experimental evidence supports the assertion that the conversion from proenzyme to enzyme occurs selectively on the surface of the tumor cells, but not on normal cells. We believe that this selectivity of activation is responsible for the antitumor/antimetastatic effect of proenzyme therapy and low toxicity to normal cells or tumor host. Elevated levels of endostatin and angiostatin appear in the blood of TG/CG/AM-treated tumor-bearing mice, but not in tumor mice treated with the vehicle alone or in proenzyme-treated tumor-free mice. These findings support the conclusion that proteolysis is the active mechanism of the proenzyme treatment. Future studies will focus on the molecular mechanisms of the proenzyme therapy including the identification of molecular target(s) on the tumor cells. In conclusion, we have discovered that proenzyme therapy, mandated first by John Beard nearly one hundred years ago, shows remarkable selective effects that result in growth inhibition of tumor cells with metastatic potential." @default.
• W2110348767 created "2016-06-24" @default.
• W2110348767 creator A5016867915 @default.
• W2110348767 creator A5043733821 @default.
• W2110348767 date "2005-05-05" @default.
• W2110348767 modified "2023-10-17" @default.
• W2110348767 title "Proenzyme therapy of cancer." @default.
• W2110348767 cites W109799418 @default.
• W2110348767 cites W119802566 @default.
• W2110348767 cites W1493910160 @default.
• W2110348767 cites W1495945591 @default.
• W2110348767 cites W1533504068 @default.
• W2110348767 cites W1536370890 @default.
• W2110348767 cites W1537206836 @default.
• W2110348767 cites W1547949248 @default.
• W2110348767 cites W1558643187 @default.
• W2110348767 cites W1579297325 @default.
• W2110348767 cites W1586300215 @default.
• W2110348767 cites W175076184 @default.
• W2110348767 cites W1755134370 @default.
• W2110348767 cites W1883537315 @default.
• W2110348767 cites W1885134561 @default.
• W2110348767 cites W189150295 @default.
• W2110348767 cites W190590421 @default.
• W2110348767 cites W1963349315 @default.
• W2110348767 cites W1965073779 @default.
• W2110348767 cites W1967945028 @default.
• W2110348767 cites W1968673560 @default.
• W2110348767 cites W1976451311 @default.
• W2110348767 cites W1978769760 @default.
• W2110348767 cites W1978968754 @default.
• W2110348767 cites W1984483611 @default.
• W2110348767 cites W1985181008 @default.
• W2110348767 cites W1987046636 @default.
• W2110348767 cites W1991900884 @default.
• W2110348767 cites W1995477592 @default.
• W2110348767 cites W1996254542 @default.
• W2110348767 cites W1999532335 @default.
• W2110348767 cites W1999675888 @default.
• W2110348767 cites W2007882456 @default.
• W2110348767 cites W2009536053 @default.
• W2110348767 cites W2009671568 @default.
• W2110348767 cites W2011220201 @default.
• W2110348767 cites W2011966283 @default.
• W2110348767 cites W2012347421 @default.
• W2110348767 cites W2014698053 @default.
• W2110348767 cites W2018847450 @default.
• W2110348767 cites W2019033162 @default.
• W2110348767 cites W2022518765 @default.
• W2110348767 cites W2025795651 @default.
• W2110348767 cites W2028201436 @default.
• W2110348767 cites W2032050847 @default.
• W2110348767 cites W2033341544 @default.
• W2110348767 cites W2035567217 @default.
• W2110348767 cites W2036920613 @default.
• W2110348767 cites W2044413205 @default.
• W2110348767 cites W2048293656 @default.
• W2110348767 cites W2057377251 @default.
• W2110348767 cites W2059215756 @default.
• W2110348767 cites W2062676851 @default.
• W2110348767 cites W2062906041 @default.
• W2110348767 cites W2064070322 @default.
• W2110348767 cites W2068733707 @default.
• W2110348767 cites W2070462390 @default.
• W2110348767 cites W2071230526 @default.
• W2110348767 cites W2076053550 @default.
• W2110348767 cites W2077656376 @default.
• W2110348767 cites W2082993484 @default.
• W2110348767 cites W2083082157 @default.
• W2110348767 cites W2083863693 @default.
• W2110348767 cites W2084127664 @default.
• W2110348767 cites W2089439064 @default.
• W2110348767 cites W2089919417 @default.
• W2110348767 cites W2089941945 @default.
• W2110348767 cites W2090395445 @default.
• W2110348767 cites W2090517304 @default.
• W2110348767 cites W2092980727 @default.
• W2110348767 cites W2093159394 @default.
• W2110348767 cites W2093812633 @default.
• W2110348767 cites W2094382824 @default.
• W2110348767 cites W2094832418 @default.
• W2110348767 cites W2098301610 @default.
• W2110348767 cites W2101844493 @default.
• W2110348767 cites W2105514170 @default.
• W2110348767 cites W2109538838 @default.
• W2110348767 cites W2110048188 @default.
• W2110348767 cites W2111272090 @default.
• W2110348767 cites W2113554746 @default.
• W2110348767 cites W2113832454 @default.
• W2110348767 cites W2122050787 @default.
• W2110348767 cites W2125779675 @default.
• W2110348767 cites W2126022125 @default.
• W2110348767 cites W2134395546 @default.
• W2110348767 cites W2137022580 @default.
• W2110348767 cites W2138752972 @default.
• W2110348767 cites W2138872911 @default.
• W2110348767 cites W2144676096 @default.
• W2110348767 cites W2147594319 @default.

• next